CNS Pharmaceuticals (CNSP) Change in Cash (2018 - 2025)

CNS Pharmaceuticals (CNSP) has 8 years of Change in Cash data on file, last reported at -$2.7 million in Q4 2025.

• Quarterly Change in Cash fell 420.39% year-over-year to -$2.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $739636.0 (down 87.49% YoY) and the FY2025 annual result came in at $739636.0, down 87.49% from the prior year.
• Change in Cash retreated to -$2.7 million in Q4 2025, from -$2.3 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $7.4 million in Q1 2022 to a low of -$4.9 million in Q1 2023.
• A 5-year average of -$341924.0 and a median of -$874499.5 in 2023 frame the typical range for Change in Cash.
• The widest YoY moves for Change in Cash: up 2371.33% in 2025, down 420.39% in 2025.
• Tracing CNSP's Change in Cash over 5 years: stood at -$3.3 million in 2021, then soared by 191.16% to $3.0 million in 2022, then plunged by 111.92% to -$360826.0 in 2023, then tumbled by 41.83% to -$511746.0 in 2024, then sank by 420.39% to -$2.7 million in 2025.
• The last three Change in Cash figures came in at -$2.7 million (Q4 2025), -$2.3 million (Q3 2025), and -$917719.0 (Q2 2025), per Business Quant data.